Key facts
- This page summarizes Jr. Robert E. Funck's Form 4 filing for ABBOTT LABORATORIES (ABT).
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 02 Mar 2023, 18:35.
Jr. Robert E. Funck - 28 Feb 2023 Form 4 Insider Report for ABBOTT LABORATORIES (ABT)
- Reporting relationship
- EXECUTIVE VICE PRESIDENT
- Issuer ticker
- ABT
- Reported as of
- 28 Feb 2023
- Net transaction value
- -$1,274,640
- SEC form
- 4
- Accepted by SEC
- 02 Mar 2023, 18:35:15 UTC
- Prior SEC filing
- 22 Feb 2023
- Next SEC filing
- 15 Sep 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Robert E. Funck, Jr. by Jessica H. Paik, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Jr. Robert E. Funck filed Form 4 for ABBOTT LABORATORIES (ABT) on 02 Mar 2023.
Change
- Previous filing in this sequence was filed on 22 Feb 2023.
- Current net transaction value: -$1,274,640.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ABT
transaction
Common shares without par value
Tax liability
- Transaction value
- $1,147,355
- Shares
- -11,500
- Change %
- -5%
- Price
- $99.77
- Shares after
- 219,501
- Date
- 28 Feb 2023
- Ownership
- Direct
ABT
transaction
Common shares without par value
Sale
- Transaction value
- $127,285
- Shares
- -1,264
- Change %
- -0.58%
- Price
- $100.70
- Shares after
- 218,237
- Date
- 01 Mar 2023
- Ownership
- Direct
ABT
holding
Common shares without par value
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 10,000
- Date
- 28 Feb 2023
- Ownership
- By Trust
- Footnotes
- F1
ABT
holding
Common shares without par value
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 10,000
- Date
- 28 Feb 2023
- Ownership
- By Trust
- Footnotes
- F1
ABT
holding
Common shares without par value
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 18,405
- Date
- 28 Feb 2023
- Ownership
- Profit Sharing Trust
- Footnotes
- F2
ABT
holding
Common shares without par value
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 500
- Date
- 28 Feb 2023
- Ownership
- By Daughter
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Held in daughter's annual gift trust. The reporting person disclaims beneficial ownership of all securities held by the trust.
Footnote F2
Balance in the Abbott Laboratories Stock Retirement Trust as of February 28, 2023.
Footnote F3
The reporting person disclaims beneficial ownership of all securities held by his daughter.
SEC remarks
The sale transaction was made pursuant to a previously adopted plan complying with Rule 10b5-1(c).